Dataset from An Open-label, Fixed-sequence, Phase 1 Study of the Effect of CYP3A4 Inhibition by Itraconazole on the Pharmacokinetics of BIIB074 in Healthy Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009315
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study is to assess the effect of cytochrome P450 (CYP) 3A4
inhibition on the pharmacokinetics (PK) of BIIB074. The secondary objectives of this study
are to assess the safety and tolerability of BIIB074 when co-administered with a strong
CYP3A4 inhibitor and to assess the effect of CYP3A4 inhibition on the PK of 3 metabolites of
BIIB074 (CNV3000497 [M13], CNV2283325 [M14], and CNV2288584 [M16]).
创建时间：
2025-07-07
